QALSODY™ is administered intrathecally in loading doses followed by maintenance doses, with careful attention to the timing between doses.

Dosage and Administration  

The recommended dose of QALSODY™ is 100 mg (15 mL) administered intrathecally. The treatment regimen starts with three loading doses, each given at 14-day intervals. After the loading phase, the patient should receive a maintenance dose every 28 days. If any doses are missed, they should be administered as soon as possible, with adjustments made based on whether the dose is a loading or maintenance. Aseptic technique should be used in preparation and administration, with the solution inspected for clarity and color prior to injection.

Tofersen(QALSODY)
Adults with amyotrophic lateral sclerosis (ALS) who have a mutation in the SOD1 gene.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved